Plain Language Study Results Summaries
What Are Plain Language Study Results Summaries?
Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries (also called layperson summaries, plain language summaries, lay language summaries, simple summaries, and trial results summaries) are intended to make the clinical results of these studies understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.
Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials. For more information about a specific study, please visit ClinicalTrials.gov on the ClinicalTrials.gov Identifier (NCT) link on the study results page.
Category & Conditions: Cancer
Study Phase : 1
Medicine: PF-06647020
PrintDownloadCategory & Conditions: Cancer
Study Phase : 3
Medicine: Xtandi (enzalutamide)
PrintDownloadCategory & Conditions: Rare Diseases
Study Phase : 2
Medicine: Domagrozumab (PF-06252616)
PrintDownloadCategory & Conditions: Vaccine-related Conditions
Study Phase : 3
Medicine: Nimenrix (meningococcal serogroups A, C, W-135 and Y conjugate vaccine)
PrintDownloadCategory & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 3
Medicine: Bococizumab (PF-04950615)
PrintDownloadCategory & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 3
Medicine: Bococizumab (PF-04950615)
PrintDownloadCategory & Conditions: Vaccine-related Conditions
Study Phase : 2
Medicine: Staphylococcus aureus 4-Antigen Vaccine (SA4Ag)
PrintDownloadCategory & Conditions: Neurological Diseases and Conditions
Study Phase : 3
Medicine: Advil (ibuprofen)
PrintDownloadCategory & Conditions: Neurological Diseases and Conditions
Study Phase : 2
Medicine: PF-06372865
PrintDownloadCategory & Conditions: Diabetes and Metabolic Disorders
Study Phase : 2
Medicine: PF-06291874
PrintDownload